POLY-RX Drug Patent Profile
Which patents cover Poly-rx, and when can generic versions of Poly-rx launch?
Poly-rx is a drug marketed by X Gen Pharms and is included in one NDA.
The generic ingredient in POLY-RX is polymyxin b sulfate. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Poly-rx
A generic version of POLY-RX was approved as polymyxin b sulfate by FRESENIUS KABI USA on January 10th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for POLY-RX?
- What are the global sales for POLY-RX?
- What is Average Wholesale Price for POLY-RX?
Summary for POLY-RX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 69 |
| DailyMed Link: | POLY-RX at DailyMed |
US Patents and Regulatory Information for POLY-RX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| X Gen Pharms | POLY-RX | polymyxin b sulfate | POWDER;FOR RX COMPOUNDING | 061578-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
